Bio Tech & Pharma Response of Tumour in Sixth Patient Prompts Expansion of Recruitment in Pancreatic Cancer Clinical TrialBy Alexander LeeSeptember 23, 20240 The positive tumour response observed in the sixth patient has resulted in the initiation of additional recruitment for the ongoing…
Bio Tech & Pharma FDA Grants Fast Track Designation to Narmafotinib for Advanced Pancreatic CancerBy Alexander LeeSeptember 20, 20240 The FDA has granted Fast Track Designation to Narmafotinib for the treatment of advanced pancreatic cancer. This designation is intended…
